HEADER TRANSFERASE/TRANSFERASE INHIBITOR 12-SEP-13 3WIG TITLE HUMAN MEK1 KINASE IN COMPLEX WITH CH5126766 AND MGAMP-PNP COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE KINASE 1, MAPKK 1, MKK1, ERK ACTIVATOR KINASE 1, COMPND 5 MAPK/ERK KINASE 1, MEK 1; COMPND 6 EC: 2.7.12.2; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: UNP RESIDUES 62-270, 303-393 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP2K1, MEK1, PRKMK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS KINASE, KINASE INHIBITOR, ALLOSTERIC, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.M.LUKACS,C.JANSON,V.SCHUCK REVDAT 5 20-MAR-24 3WIG 1 REMARK LINK REVDAT 4 25-DEC-19 3WIG 1 REMARK SEQADV REVDAT 3 22-NOV-17 3WIG 1 REMARK REVDAT 2 16-AUG-17 3WIG 1 SOURCE REMARK REVDAT 1 04-JUN-14 3WIG 0 JRNL AUTH P.LITO,A.SABOROWSKI,J.YUE,M.SOLOMON,E.JOSEPH,S.GADAL, JRNL AUTH 2 M.SABOROWSKI,E.KASTENHUBER,C.FELLMANN,K.OHARA,K.MORIKAMI, JRNL AUTH 3 T.MIURA,C.LUKACS,N.ISHII,S.LOWE,N.ROSEN JRNL TITL DISRUPTION OF CRAF-MEDIATED MEK ACTIVATION IS REQUIRED FOR JRNL TITL 2 EFFECTIVE MEK INHIBITION IN KRAS MUTANT TUMORS JRNL REF CANCER CELL V. 25 697 2014 JRNL REFN ISSN 1535-6108 JRNL PMID 24746704 JRNL DOI 10.1016/J.CCR.2014.03.011 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1132132.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 17775 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 896 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2910 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2900 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.311 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 896 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0100 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 17775 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 17 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1000 REMARK 3 BIN R VALUE (WORKING SET) : 0.3353 REMARK 3 BIN FREE R VALUE : 0.3096 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 43 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2179 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 83 REMARK 3 SOLVENT ATOMS : 16 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -16.53000 REMARK 3 B22 (A**2) : -16.53000 REMARK 3 B33 (A**2) : 33.06000 REMARK 3 B12 (A**2) : -2.65000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.49 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.42 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.53 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.620 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.170 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.020 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.900 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.980 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 43.31 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : LIG.PARAM REMARK 3 PARAMETER FILE 5 : ANP2.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : LIG.TOP REMARK 3 TOPOLOGY FILE 5 : ANP2.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3WIG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-OCT-13. REMARK 100 THE DEPOSITION ID IS D_1000096375. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-MAR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97929 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45559 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 34.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09100 REMARK 200 FOR THE DATA SET : 8.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 1.09300 REMARK 200 FOR SHELL : 0.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 73.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7.5-10% PEG 8000, 0.2M NACL, 0.2M REMARK 280 AMMONIUM SULFATE, 0.1M CITRATE BUFFER, PH 4.2, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 19.92133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.84267 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 39.84267 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 19.92133 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 39.84267 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 79 REMARK 465 GLY A 80 REMARK 465 GLY A 81 REMARK 465 ASP A 299 REMARK 465 ALA A 300 REMARK 465 LYS A 301 REMARK 465 GLU A 302 REMARK 465 ASP A 303 REMARK 465 SER A 304 REMARK 465 ARG A 305 REMARK 465 LEU A 381 REMARK 465 ASN A 382 REMARK 465 GLN A 383 REMARK 465 PRO A 384 REMARK 465 SER A 385 REMARK 465 THR A 386 REMARK 465 PRO A 387 REMARK 465 THR A 388 REMARK 465 HIS A 389 REMARK 465 ALA A 390 REMARK 465 ALA A 391 REMARK 465 GLY A 392 REMARK 465 VAL A 393 REMARK 465 HIS A 394 REMARK 465 HIS A 395 REMARK 465 HIS A 396 REMARK 465 HIS A 397 REMARK 465 HIS A 398 REMARK 465 HIS A 399 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 63 87.98 62.14 REMARK 500 HIS A 185 -0.50 -140.95 REMARK 500 ARG A 190 -9.66 78.66 REMARK 500 ASP A 191 52.38 -148.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 326 SER A 327 -147.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 402 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 196 OD1 REMARK 620 2 ASP A 209 OD2 105.8 REMARK 620 3 ANP A 401 O2B 94.1 152.1 REMARK 620 4 ANP A 401 O2A 169.9 83.6 75.8 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHU A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 408 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 409 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ORN RELATED DB: PDB REMARK 900 RELATED ID: 3OS3 RELATED DB: PDB DBREF 3WIG A 63 302 UNP Q02750 MP2K1_HUMAN 62 270 DBREF 3WIG A 303 393 UNP Q02750 MP2K1_HUMAN 303 393 SEQADV 3WIG MET A 62 UNP Q02750 EXPRESSION TAG SEQADV 3WIG HIS A 394 UNP Q02750 EXPRESSION TAG SEQADV 3WIG HIS A 395 UNP Q02750 EXPRESSION TAG SEQADV 3WIG HIS A 396 UNP Q02750 EXPRESSION TAG SEQADV 3WIG HIS A 397 UNP Q02750 EXPRESSION TAG SEQADV 3WIG HIS A 398 UNP Q02750 EXPRESSION TAG SEQADV 3WIG HIS A 399 UNP Q02750 EXPRESSION TAG SEQRES 1 A 307 MET GLU LEU LYS ASP ASP ASP PHE GLU LYS ILE SER GLU SEQRES 2 A 307 LEU GLY ALA GLY ASN GLY GLY VAL VAL PHE LYS VAL SER SEQRES 3 A 307 HIS LYS PRO SER GLY LEU VAL MET ALA ARG LYS LEU ILE SEQRES 4 A 307 HIS LEU GLU ILE LYS PRO ALA ILE ARG ASN GLN ILE ILE SEQRES 5 A 307 ARG GLU LEU GLN VAL LEU HIS GLU CYS ASN SER PRO TYR SEQRES 6 A 307 ILE VAL GLY PHE TYR GLY ALA PHE TYR SER ASP GLY GLU SEQRES 7 A 307 ILE SER ILE CYS MET GLU HIS MET ASP GLY GLY SER LEU SEQRES 8 A 307 ASP GLN VAL LEU LYS LYS ALA GLY ARG ILE PRO GLU GLN SEQRES 9 A 307 ILE LEU GLY LYS VAL SER ILE ALA VAL ILE LYS GLY LEU SEQRES 10 A 307 THR TYR LEU ARG GLU LYS HIS LYS ILE MET HIS ARG ASP SEQRES 11 A 307 VAL LYS PRO SER ASN ILE LEU VAL ASN SER ARG GLY GLU SEQRES 12 A 307 ILE LYS LEU CYS ASP PHE GLY VAL SER GLY GLN LEU ILE SEQRES 13 A 307 ASP SER MET ALA ASN SER PHE VAL GLY THR ARG SER TYR SEQRES 14 A 307 MET SER PRO GLU ARG LEU GLN GLY THR HIS TYR SER VAL SEQRES 15 A 307 GLN SER ASP ILE TRP SER MET GLY LEU SER LEU VAL GLU SEQRES 16 A 307 MET ALA VAL GLY ARG TYR PRO ILE PRO PRO PRO ASP ALA SEQRES 17 A 307 LYS GLU ASP SER ARG PRO PRO MET ALA ILE PHE GLU LEU SEQRES 18 A 307 LEU ASP TYR ILE VAL ASN GLU PRO PRO PRO LYS LEU PRO SEQRES 19 A 307 SER GLY VAL PHE SER LEU GLU PHE GLN ASP PHE VAL ASN SEQRES 20 A 307 LYS CYS LEU ILE LYS ASN PRO ALA GLU ARG ALA ASP LEU SEQRES 21 A 307 LYS GLN LEU MET VAL HIS ALA PHE ILE LYS ARG SER ASP SEQRES 22 A 307 ALA GLU GLU VAL ASP PHE ALA GLY TRP LEU CYS SER THR SEQRES 23 A 307 ILE GLY LEU ASN GLN PRO SER THR PRO THR HIS ALA ALA SEQRES 24 A 307 GLY VAL HIS HIS HIS HIS HIS HIS HET ANP A 401 31 HET MG A 402 1 HET CHU A 403 33 HET PG4 A 404 13 HET CL A 405 1 HET CL A 406 1 HET CL A 407 1 HET CL A 408 1 HET CL A 409 1 HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER HETNAM MG MAGNESIUM ION HETNAM CHU N-(3-FLUORO-4-{[4-METHYL-2-OXO-7-(PYRIMIDIN-2-YLOXY)- HETNAM 2 CHU 2H-CHROMEN-3-YL]METHYL}PYRIDIN-2-YL)-N'-METHYLSULFURIC HETNAM 3 CHU DIAMIDE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM CL CHLORIDE ION HETSYN CHU CH5126766 FORMUL 2 ANP C10 H17 N6 O12 P3 FORMUL 3 MG MG 2+ FORMUL 4 CHU C21 H18 F N5 O5 S FORMUL 5 PG4 C8 H18 O5 FORMUL 6 CL 5(CL 1-) FORMUL 11 HOH *16(H2 O) HELIX 1 1 LYS A 65 ASP A 67 5 3 HELIX 2 2 LYS A 105 GLN A 117 1 13 HELIX 3 3 VAL A 118 CYS A 122 5 5 HELIX 4 4 SER A 151 GLY A 160 1 10 HELIX 5 5 PRO A 163 HIS A 185 1 23 HELIX 6 6 LYS A 193 SER A 195 5 3 HELIX 7 7 SER A 213 ALA A 221 1 9 HELIX 8 8 ASN A 222 VAL A 225 5 4 HELIX 9 9 GLU A 234 GLY A 238 5 5 HELIX 10 10 SER A 242 GLY A 260 1 19 HELIX 11 11 ALA A 309 GLU A 320 1 12 HELIX 12 12 SER A 331 LEU A 342 1 12 HELIX 13 13 ASP A 351 VAL A 357 1 7 HELIX 14 14 HIS A 358 GLU A 367 1 10 HELIX 15 15 ASP A 370 GLY A 380 1 11 SHEET 1 A 5 PHE A 69 GLY A 76 0 SHEET 2 A 5 VAL A 83 HIS A 88 -1 O LYS A 85 N ILE A 72 SHEET 3 A 5 VAL A 94 HIS A 101 -1 O ARG A 97 N PHE A 84 SHEET 4 A 5 GLU A 139 GLU A 145 -1 O MET A 144 N ALA A 96 SHEET 5 A 5 PHE A 130 SER A 136 -1 N PHE A 134 O SER A 141 SHEET 1 B 2 ILE A 197 VAL A 199 0 SHEET 2 B 2 ILE A 205 LEU A 207 -1 O LYS A 206 N LEU A 198 LINK OD1 ASN A 196 MG MG A 402 1555 1555 2.11 LINK OD2 ASP A 209 MG MG A 402 1555 1555 2.18 LINK O2B ANP A 401 MG MG A 402 1555 1555 2.02 LINK O2A ANP A 401 MG MG A 402 1555 1555 2.19 CISPEP 1 ILE A 264 PRO A 265 0 -1.27 SITE 1 AC1 15 LEU A 75 ALA A 77 GLY A 78 ALA A 96 SITE 2 AC1 15 LYS A 98 GLU A 145 MET A 147 SER A 151 SITE 3 AC1 15 GLN A 154 LYS A 193 SER A 195 ASN A 196 SITE 4 AC1 15 LEU A 198 ASP A 209 MG A 402 SITE 1 AC2 3 ASN A 196 ASP A 209 ANP A 401 SITE 1 AC3 17 LEU A 119 VAL A 128 GLY A 129 ILE A 142 SITE 2 AC3 17 MET A 144 HIS A 189 ARG A 190 ASP A 191 SITE 3 AC3 17 ASP A 209 PHE A 210 GLY A 211 VAL A 212 SITE 4 AC3 17 SER A 213 LEU A 216 ILE A 217 MET A 220 SITE 5 AC3 17 ASN A 222 SITE 1 AC4 4 GLY A 211 VAL A 212 GLY A 214 GLN A 215 SITE 1 AC5 3 ARG A 182 SER A 242 VAL A 243 SITE 1 AC6 1 THR A 227 SITE 1 AC7 1 PHE A 371 SITE 1 AC8 2 SER A 331 LEU A 332 SITE 1 AC9 1 HIS A 240 CRYST1 136.366 136.366 59.764 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007333 0.004234 0.000000 0.00000 SCALE2 0.000000 0.008468 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016732 0.00000